Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2016 061 011.6 |
96 | EP file number | EAKZ | 16 81 5196.7 |
86 | WO file number | WAKZ | PCT/US2016/038702 |
97 | EP publication number | EPN | 3310386 |
87 | WO publication number | WPN | 2016209921 |
54 | Designation/title | TI | KOMBINATIONSTHERAPIEN FÜR BLUTMALIGNOME MIT ANTI-CD38-ANTIKÖRPERN SURVIVIN-INHIBITOREN |
51 | IPC main class | ICM (ICMV) | A61K 39/395 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61P 35/00 (2006.01), C07K 16/18 (2006.01), C07K 16/28 (2006.01) |
22 | DE application date | DAT | Jun 22, 2016 |
96 | EP application date | EAT | Jun 22, 2016 |
86 | WO application date | WAT | Jun 22, 2016 |
43 | Date of first publication | OT | Dec 29, 2016 |
| Date of publication of grant | PET | Jul 21, 2021 |
71/73 | Applicant/owner | INH | Janssen Biotech, Inc., Horsham, PA, US |
72 | Inventor | IN | DOSHI, Parul, Chester Springs , PA 19425, US; LOKHORST, Henk, M., 1081 HV Amsterdam, NL; MUTIS, Tuna, 1081 HV Amsterdam, NL |
74 | Representative | VTR | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
| Address for service | | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201562182699 P Jun 22, 2015
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201662319036 P Apr 6, 2016
|
| Due date | FT FG | Jun 30, 2026 Annual fee for the 11th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003310386A1 Searchable text:
EP000003310386A1 Original document:
EP000003310386B1 Searchable text:
EP000003310386B1 Original document:
WO002016209921 Searchable text:
WO002016209921 |
43 | Date of first publication | EVT | Dec 29, 2016 |
| Date of the first transfer into DPMAregister | EREGT | Apr 25, 2018 |
| Date of the (most recent) update in DPMAregister | REGT | May 7, 2025 (Show all update days)(Hide all update days)- May 7, 2025
- Due date: changed
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 21.07.2021: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 21.07.2021: deleted
- Sep 26, 2024
- St.36: changed (technical change)
- Sep 3, 2024
- St.36: changed (technical change)
- Jun 27, 2024; May 14, 2024; May 9, 2024; Apr 25, 2024; May 10, 2023; Jun 30, 2022; Jun 9, 2022; May 14, 2022; Aug 12, 2021; Jul 9, 2021; Jul 2, 2021; Jul 1, 2021; Aug 23, 2019; Jul 18, 2019
- Historical data not available for this/these date(s)
- Apr 25, 2018
- Date of the first transfer into DPMAregister
|